---
id: 015
title: Target Modification Mechanisms of Resistance
category: antimicrobials
subcategory: resistance_mechanisms
tags: [resistance, target-modification, mecA, MRSA, VRSA]
difficulty: medium
---

## Question

What are three major examples of **target modification** as a resistance mechanism, and how do they confer resistance?

## Answer

| Resistance Phenotype | Target Modification | Mechanism |
|---------------------|---------------------|-----------|
| **MRSA** | *mecA* gene → PBP2a | Altered penicillin-binding protein with low affinity for β-lactams |
| **Vancomycin-resistant *Enterococcus*** | *vanA* gene cluster | D-Ala-D-Ala → D-Ala-D-Lac substitution in peptidoglycan precursor (1000× ↓ vancomycin binding) |
| **Fluoroquinolone resistance** | *gyrA*, *parC* mutations | Point mutations in DNA gyrase/topoisomerase IV (target enzymes) |
| **Macrolide resistance** | *erm* genes | Ribosomal methylation (prevents macrolide binding to 23S rRNA) |

## Key Points

### **MRSA/PBP2a:**
- PBP2a has 100-1000× lower affinity for β-lactams
- Only β-lactam active against MRSA: **ceftaroline** (5th-gen cephalosporin)

### **VRE:**
- **VanA:** High-level resistance (MIC >256 μg/mL) to vancomycin and teicoplanin
- **VanB:** Variable vancomycin resistance, teicoplanin-susceptible

### **Cross-Resistance:**
- *erm* genes confer **MLSB resistance** (Macrolides, Lincosamides, Streptogramin B)
- Constitutive (*ermA*, *ermC*) vs inducible (*ermB*) expression

## Sources

- [PMC6604941: Overview of antimicrobial resistance mechanisms]
- [PMC5672523: Action and resistance mechanisms of antibiotics]

## Media

N/A
